S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Bank Accounts: Frozen! (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Bank Accounts: Frozen! (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
NYSE:CHE

Chemed - CHE Stock Forecast, Price & News

$526.39
+3.62 (+0.69%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$524.46
$530.19
50-Day Range
$493.18
$535.55
52-Week Range
$430.16
$539.13
Volume
55,921 shs
Average Volume
75,235 shs
Market Capitalization
$7.87 billion
P/E Ratio
31.84
Dividend Yield
0.29%
Price Target
$587.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
11.5% Upside
$587.00 Price Target
Short Interest
Healthy
2.97% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
0.40mentions of Chemed in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$3.11 M Sold Last Quarter
Proj. Earnings Growth
8.39%
From $20.85 to $22.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

76th out of 995 stocks

Home Health Care Services Industry

4th out of 9 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
Chemed (NYSE:CHE) Research Coverage Started at StockNews.com
Chemed Full Year 2022 Earnings: EPS Misses Expectations
Q4 2022 Chemed Corp Earnings Call
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Chemed (CHE) Tops Q4 Earnings and Revenue Estimates
Chemed Reports Fourth-Quarter 2022 Results
Chemed Q4 2022 Earnings Preview
PNTG vs. CHE: Which Stock Is the Better Value Option?
Chemed (CHE) Q3 Earnings Surpass Estimates, EPS View Up
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
2/24/2023
Ex-Dividend for 3/17 Dividend
2/24/2023
Dividend Payable
3/17/2023
Today
3/27/2023
Next Earnings (Estimated)
4/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,167
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$587.00
High Stock Price Forecast
$587.00
Low Stock Price Forecast
$587.00
Forecasted Upside/Downside
+11.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$249.62 million
Pretax Margin
15.44%

Debt

Sales & Book Value

Annual Sales
$2.13 billion
Cash Flow
$24.22 per share
Book Value
$53.71 per share

Miscellaneous

Free Float
14,346,000
Market Cap
$7.87 billion
Optionable
Optionable
Beta
0.52

Social Links


Key Executives

  • Kevin J. McNamaraKevin J. McNamara
    President, Chief Executive Officer & Director
  • David Patrick WilliamsDavid Patrick Williams
    Chief Financial Officer & Executive Vice President
  • Spencer S. LeeSpencer S. Lee
    Executive Vice President
  • Nicholas M. WestfallNicholas M. Westfall
    Executive Vice President
  • Thomas C. Hutton
    Director & Vice President













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 Wall Street research analysts have issued 1-year price objectives for Chemed's shares. Their CHE share price forecasts range from $587.00 to $587.00. On average, they expect the company's stock price to reach $587.00 in the next year. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the start of the year. Since then, CHE stock has increased by 3.7% and is now trading at $529.27.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 432,300 shares, a decline of 15.6% from the February 28th total of 512,000 shares. Based on an average daily volume of 73,600 shares, the days-to-cover ratio is presently 5.9 days. Approximately 3.0% of the company's stock are sold short.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its quarterly earnings data on Friday, February, 24th. The company reported $5.39 EPS for the quarter, beating the consensus estimate of $5.30 by $0.09. The business had revenue of $546.65 million for the quarter, compared to the consensus estimate of $546.60 million. Chemed had a net margin of 11.69% and a trailing twelve-month return on equity of 41.54%. The company's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $5.25 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, February 17th. Stockholders of record on Monday, February 27th will be paid a dividend of $0.38 per share on Friday, March 17th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date is Friday, February 24th.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.30%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share guidance of $20.75-$21.10 for the period, compared to the consensus EPS estimate of $20.21. The company issued revenue guidance of $2.24 billion-$2.25 billion, compared to the consensus revenue estimate of $2.21 billion.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of institutional and retail investors. Top institutional investors include Neuberger Berman Group LLC (3.62%), William Blair Investment Management LLC (3.37%), Morgan Stanley (2.44%), Geode Capital Management LLC (1.68%), JPMorgan Chase & Co. (1.65%) and Victory Capital Management Inc. (1.54%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends
.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $529.27.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $7.91 billion and generates $2.13 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $16.53 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,167 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 3/28/2023 by MarketBeat.com Staff